Trius Therapeutics

Company Website

6310 Nancy Ridge Dr. Ste., 105
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Trius Therapeutics

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$402,604,553

Market Cap as of 06/26/2012

$225,061,249

Market Cap as of 01/04/2012

$192,751,600

Market Cap as of 06/20/2011

$178,925,000

Market Cap as of 01/06/2011

$92,790,530

Exchange and Ticker Symbol

Nasdaq: TRSX

Fields of Research

Discovery, development and commercialization of antibiotics for life-threatening infections

Major Products

Tedizolid phosphate

View all the companies in San Diego Publicly Traded Companies

Trius Therapeutics

Market Cap as of 6/12/2015

Exchange

NASDAQ GM

Ticker

TSRX

Executives

John Schmid

  • Chief Financial Officer

Jeffrey Stein

  • Chief Executive Officer
  • President